Fundraising FoxPhoenix SENOLYTIX
Houston, US · 1 known investors
Find your way into Phoenix SENOLYTIX
Sign up to see every warm intro you have to Phoenix SENOLYTIX
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Phoenix SENOLYTIX team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Phoenix SENOLYTIX develops gene therapies targeting senescent cells to address aging-related conditions. The company utilizes its ApoptiCIDe-CE™ platform technology, validated in human patients, to eliminate unwanted cells in the body.
Founders & leadership
KS
Kevin Slawin, M.D.Founder and CEOKevin Slawin is a physician and biotech entrepreneur who co-founded Bellicum Pharmaceuticals and led it to a $161 million IPO in 2014. He is founder and CEO of Phoenix SENOLYTIX, which develops gene therapies targeting senescent cells to address aging-related diseases.
Investors · 1
Frequently asked questions
- What does Phoenix SENOLYTIX do?
- Phoenix SENOLYTIX develops gene therapies targeting senescent cells to address aging-related conditions. The company utilizes its ApoptiCIDe-CE™ platform technology, validated in human patients, to eliminate unwanted cells in the body.
- Who founded Phoenix SENOLYTIX?
- Phoenix SENOLYTIX was founded by Kevin Slawin, M.D..
- Who are Phoenix SENOLYTIX's investors?
- Phoenix SENOLYTIX's investors include Rapha Capital Management, LLC.
- Where is Phoenix SENOLYTIX headquartered?
- Phoenix SENOLYTIX is headquartered in Houston, US.